CytoMed Therapeutics Limited (GDTC)
NASDAQ: GDTC · Real-Time Price · USD
1.020
+0.073 (7.72%)
At close: Feb 13, 2026, 4:00 PM EST
1.000
-0.020 (-1.96%)
After-hours: Feb 13, 2026, 7:52 PM EST

CytoMed Therapeutics Revenue

CytoMed Therapeutics had revenue of 450.69K SGD in the half year ending June 30, 2025, with 58.57% growth. This brings the company's revenue in the last twelve months to 729.88K, up 63.03% year-over-year. In the year 2024, CytoMed Therapeutics had annual revenue of 503.37K, down -0.86%.

Revenue (ttm)
729.88K SGD
Revenue Growth
+63.03%
P/S Ratio
20.54
Revenue / Employee
16,974 SGD
Employees
43
Market Cap
11.77M USD

Revenue Chart

* This company reports financials in SGD.

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2024503.37K-4.36K-0.86%
Dec 31, 2023507.74K143.82K39.52%
Dec 31, 2022363.91K250.07K219.67%
Dec 31, 2021113.84K54.37K91.43%
Dec 31, 202059.47K--
Dec 31, 2019 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition